{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:37:09Z","timestamp":1768019829814,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05530-7","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T21:52:26Z","timestamp":1741038746000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary management of prostate cancer by universal health coverage effective coverage index"],"prefix":"10.1007","volume":"43","author":[{"given":"Leandro","family":"Blas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Shiota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Onozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Young","family":"Joung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyo Chul","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"T\u00fcrkeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahad\u0131r","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng Aik","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Ka-Fung","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Fai","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong-Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vu","family":"Le Chuyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bannakij","family":"Lojanapiwat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason L.","family":"Letran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukman","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund","family":"Chiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazi M.","family":"Al-Edwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketo","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Eto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Hinotsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Kume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Asian Prostate Cancer (A-CaP)\u00a0study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"6","key":"5530_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492. (Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313. 10.3322\/caac.21609. PMID: 30207593)","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"5530_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/iju.13593","volume":"25","author":"T Kimura","year":"2018","unstructured":"Kimura T, Egawa S (2018) Epidemiology of prostate cancer in Asian countries. Int J Urol 25(6):524\u2013531. https:\/\/doi.org\/10.1111\/iju.13593. (Epub 2018 May 8. PMID: 29740894)","journal-title":"Int J Urol"},{"issue":"3","key":"5530_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834. (Epub 2024 Apr 4. PMID: 38572751)","journal-title":"CA Cancer J Clin"},{"issue":"10258","key":"5530_CR4","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/S0140-6736(20)30750-9","volume":"396","author":"GBD 2019 Universal Health Coverage Collaborators","year":"2020","unstructured":"GBD 2019 Universal Health Coverage Collaborators (2020) Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258):1250\u20131284. https:\/\/doi.org\/10.1016\/S0140-6736(20)30750-9. (Epub 2020 Aug 27. PMID: 32861314; PMCID: PMC7562819)","journal-title":"Lancet"},{"issue":"3","key":"5530_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.prnil.2016.03.001","volume":"4","author":"H Akaza","year":"2016","unstructured":"Akaza H, Hirao Y, Kim CS, Oya M, Ozono S, Ye D et al (2016) Asia prostate cancer study (A-CaP Study) launch symposium. Prostate Int 4(3):88\u201396. https:\/\/doi.org\/10.1016\/j.prnil.2016.03.001. (Epub 2016 Mar 10. PMID: 27689065; PMCID: PMC5031897)","journal-title":"Prostate Int"},{"issue":"6","key":"5530_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/jjco\/hyz053","volume":"49","author":"J Youl Lee","year":"2019","unstructured":"Youl Lee J, Taniguchi T, Zhang K, Ng CF, Hakim L, Umbas R et al (2019) Report of the forth Asian prostate cancer (A-CaP) study meeting. Jpn J Clin Oncol 49(6):581\u2013586. https:\/\/doi.org\/10.1093\/jjco\/hyz053. (PMID: 31141613)","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"5530_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.prnil.2018.06.001","volume":"7","author":"B Lojanapiwat","year":"2019","unstructured":"Lojanapiwat B, Lee JY, Gang Z, Kim CS, Fai NC, Hakim L et al (2019) Report of the third Asian prostate cancer\u00a0study meeting. Prostate Int 7(2):60\u201367. https:\/\/doi.org\/10.1016\/j.prnil.2018.06.001. (Epub 2018 Jun 14. PMID: 31384607; PMCID: PMC6664304)","journal-title":"Prostate Int"},{"issue":"3","key":"5530_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.prnil.2017.03.006","volume":"5","author":"CS Kim","year":"2017","unstructured":"Kim CS, Lee JY, Chung BH, Kim WJ, Fai NC, Hakim L et al (2017) Report of the second Asian prostate cancer (A-CaP) study meeting. Prostate Int 5(3):95\u2013103. https:\/\/doi.org\/10.1016\/j.prnil.2017.03.006. (Epub 2017 Mar 29. PMID: 28828352; PMCID: PMC5551923)","journal-title":"Prostate Int"},{"issue":"6","key":"5530_CR9","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1111\/cas.14889","volume":"112","author":"J Lim","year":"2021","unstructured":"Lim J, Onozawa M, Saad M, Ong TA, Malek R, Akaza H, A-CaP (Asian Prostate Cancer), Study J-CaP (Japan Prostate Cancer Study Group), M-CaP (Malaysia Prostate Cancer Study Group) (2021) Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: comparing between high- and middle-income Asian countries. Cancer Sci 112(6):2071\u20132080. https:\/\/doi.org\/10.1111\/cas.14889. (Epub 2021 May 3. PMID: 33738901; PMCID: PMC8177804)","journal-title":"Cancer Sci"},{"key":"5530_CR10","unstructured":"Malaysia National Cancer Registry report (2012\u20132016). https:\/\/www.moh.gov.my. Accessed 6 Aug 2024"},{"issue":"8","key":"5530_CR11","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/jjco\/hyv066","volume":"45","author":"R Umbas","year":"2015","unstructured":"Umbas R, Safriadi F, Mochtar CA, Djatisoesanto W, Hamid AR (2015) Urologic cancer in Indonesia. Jpn J Clin Oncol 45(8):708\u2013712. https:\/\/doi.org\/10.1093\/jjco\/hyv066. (Epub 2015 Jun 16. PMID: 26085688)","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"5530_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/bju.14489","volume":"123","author":"E Chiong","year":"2019","unstructured":"Chiong E, Murphy DG, Akaza H, Buchan NC, Chung BH, Kanesvaran R et al (2019) Management of patients with advanced prostate cancer in the Asia pacific region: \u2018real-world\u2019 consideration of results from the advanced prostate cancer consensus conference (APCCC) 2017. BJU Int 123(1):22\u201334. https:\/\/doi.org\/10.1111\/bju.14489. (Epub 2018 Aug 19. PMID: 30019467)","journal-title":"BJU Int"},{"issue":"17","key":"5530_CR13","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.3390\/cancers14174161","volume":"14","author":"L Blas","year":"2022","unstructured":"Blas L, Shiota M, Eto M (2022) Active surveillance in intermediate-risk prostate cancer: a review of the current data. Cancers (Basel) 14(17):4161. https:\/\/doi.org\/10.3390\/cancers14174161. (PMID:36077698; PMCID:PMC9454661)","journal-title":"Cancers (Basel)"},{"key":"5530_CR14","doi-asserted-by":"publisher","first-page":"S2588-9311(24)0","DOI":"10.1016\/j.euo.2024.07.003","volume":"17","author":"C Bangma","year":"2024","unstructured":"Bangma C, Doan P, Zhu L, Remmers S, Nieboer D, Helleman J, Movember Foundation\u2019s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium et al (2024) Has active surveillance for prostate cancer become safer? Lessons learned from a global clinical registry. Eur Urol Oncol 17:S2588-9311(24)00176\u20137. https:\/\/doi.org\/10.1016\/j.euo.2024.07.003. (Epub ahead of print. PMID: 39025687)","journal-title":"Eur Urol Oncol"},{"issue":"11","key":"5530_CR15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/iju.14977","volume":"29","author":"T Kato","year":"2022","unstructured":"Kato T, Yokomizo A, Matsumoto R, Tohi Y, Miyakawa J, Mitsuzuka K et al (2022) Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN study. Int J Urol 29(11):1271\u20131278. https:\/\/doi.org\/10.1111\/iju.14977. (Epub 2022 Jul 19 PMID: 35855586)","journal-title":"Int J Urol"},{"issue":"4","key":"5530_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1349-7006.2006.00180.x","volume":"97","author":"H Akaza","year":"2006","unstructured":"Akaza H (2006) Trends in primary androgen depletion therapy for patients with localized and locally advanced prostate cancer: Japanese perspective. Cancer Sci 97(4):243\u2013247. https:\/\/doi.org\/10.1111\/j.1349-7006.2006.00180.x. (PMID:16630114;PMCID: PMC11160009)","journal-title":"Cancer Sci"},{"issue":"8","key":"5530_CR17","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1111\/cas.14974","volume":"112","author":"L Blas","year":"2021","unstructured":"Blas L, Onozawa M, Shiota M, Hinotsu S, Sakamoto S, Kitagawa Y, Japan Study Group of Prostate Cancer (J-CaP) et al (2021) Long-term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80\u00a0years old. Cancer Sci 112(8):3074\u20133082. https:\/\/doi.org\/10.1111\/cas.14974. (Epub 2021 Jun 29. PMID: 34014592; PMCID: PMC8353900)","journal-title":"Cancer Sci"},{"issue":"1","key":"5530_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1442-2042.2004.00984.x","volume":"12","author":"Cancer Registration Committee of the Japanese Urological Association","year":"2005","unstructured":"Cancer Registration Committee of the Japanese Urological Association (2005) Clinicopathological statistics on registered prostate cancer patients in Japan\u202f: 2000 report from the Japanese Urological Association. Int J Urol 12(1):46\u201361. https:\/\/doi.org\/10.1111\/j.1442-2042.2004.00984.x. (PMID: 15661054)","journal-title":"Int J Urol"},{"key":"5530_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2022.100606","volume":"32","author":"L Blas","year":"2022","unstructured":"Blas L, Shiota M, Eto M (2022) Current status and future perspective on the management of metastatic castration-sensitive prostate cancer. Cancer Treat Res Commun 32:100606. https:\/\/doi.org\/10.1016\/j.ctarc.2022.100606. (Epub 2022 Jul 9. PMID: 35835707)","journal-title":"Cancer Treat Res Commun"},{"issue":"3","key":"5530_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/bju.14807","volume":"124","author":"M Saad","year":"2019","unstructured":"Saad M, Alip A, Lim J, Abdullah MM, Chong FLT, Chua CB et al (2019) Management of advanced prostate cancer in a middle-income country: real-world consideration of the advanced prostate cancer consensus conference 2017. BJU Int 124(3):373\u2013382. https:\/\/doi.org\/10.1111\/bju.14807. (Epub 2019 Jun 17. PMID: 31077523; PMCID: PMC6851975)","journal-title":"BJU Int"},{"issue":"16","key":"5530_CR21","doi-asserted-by":"publisher","first-page":"175883592312165","DOI":"10.1177\/17588359231216582","volume":"18","author":"E Chiong","year":"2024","unstructured":"Chiong E, Saad M, Hamid ARAH, Ong-Cornel AB, Lojanapiwat B, Pripatnanont C et al (2024) Prostate cancer management in Southeast Asian countries: a survey of clinical practice patterns. Ther Adv Med Oncol 18(16):17588359231216582. https:\/\/doi.org\/10.1177\/17588359231216582. (PMID:38249332; PMCID: PMC10798109)","journal-title":"Ther Adv Med Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05530-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05530-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05530-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:03:59Z","timestamp":1767996239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05530-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5530"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05530-7","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from each participant, or the opportunity to opt-out was provided.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Approval was received from the institutional review boards of all participating institutions.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Approval of the research protocol by an institutional reviewer board"}}],"article-number":"146"}}